Three-dimensional conformal radiotherapy (3DCRT) combined with transcatheter arterial chemoembolization (TACE) for inoperable or unresectable hepatocellular carcinoma (HCC): Clinical phase I/II trial

被引：0
|
作者：
Jiang, G
Zhou, Z
Liu, L
机构：
[1] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China
[2] Fudan Univ, Canc Hosp, Dept Integrat Chinese & Western Med, Shanghai 200433, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1027
引用
收藏
页码：S160 / S161
页数：2
相关论文
共 50 条
  • [31] Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
    Chen, Hui
    Nan, Gang
    Wei, Ding
    Zhai, Ren-You
    Huang, Ming
    Yang, Wu-Wei
    Xing, Bao-Cai
    Zhu, Xu
    Xu, Hai-Feng
    Wang, Xiao-Dong
    Zhang, Xiao-Yong
    Zhu, Bao-Rang
    Liu, Peng
    Cao, Guang
    Gao, Song
    Hao, Chun-Yi
    Yang, Ren-Jie
    Guo, Jian-Hai
    Zhang, Xin
    Gao, Kun
    Wang, Kun
    Wang, Jian-Feng
    Li, Zi-Yu
    Zhu, Lin-Zhong
    Ding, Rong
    Li, Jing
    Zhao, Ling
    Shao, Yu-Jun
    Liu, Hai-Chun
    Xia, Jie-Lai
    Wang, Ling
    Kong, Ling-Min
    Chen, Zhi-Nan
    Bian, Huijie
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (04) : 556 - 559
  • [32] The efficacy and safety of transarterial chemoembolization combined with cadonilimab and lenvatinib for unresectable hepatocellular carcinoma: A phase II clinical trial
    Liang, Guo
    Gu, Shanzhi
    Guo, Yabing
    Li, Hailiang
    Liu, Jingfeng
    Liu, Jibing
    Huang, Ming
    Zou, Yinghua
    Huang, Luke
    Zhang, Yangyang
    Liu, Ting
    Liu, Wei
    Wang, Zhongmin
    Li, Baiyong
    Xia, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 478 - 478
  • [33] Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study
    Jian-Dong Zhao
    Jin Liu
    Zhi-Gang Ren
    Ke Gu
    Zhen-Hua Zhou
    Wen-Tao Li
    Zhen Chen
    Zhi-Yong Xu
    Lu-Ming Liu
    Guo-Liang Jiang
    Radiation Oncology, 5
  • [34] Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study
    Zhao, Jian-Dong
    Liu, Jin
    Ren, Zhi-Gang
    Gu, Ke
    Zhou, Zhen-Hua
    Li, Wen-Tao
    Chen, Zhen
    Xu, Zhi-Yong
    Liu, Lu-Ming
    Jiang, Guo-Liang
    RADIATION ONCOLOGY, 2010, 5
  • [35] Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients
    Seong, J
    Park, HC
    Han, KH
    Chon, CY
    Chu, SS
    Kim, GE
    Suh, CO
    HEPATOLOGY RESEARCH, 2003, 27 (01) : 30 - 35
  • [36] Comparison of bone marrow sparing intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in carcinoma of anal canal: a prospective study
    Rattan, Rajit
    Kapoor, Rakesh
    Bahl, Amit
    Gupta, Rajesh
    Oinam, Arun S.
    Kaur, Satinder
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (04)
  • [37] Clinical results of inoperable hepatocellular carcinoma treated with three-dimensional conformal radiotherapy: factors affecting the tumor response and survival rate
    Maeda, S.
    Hayashi, S.
    Matsuo, M.
    Kanematsu, M.
    Tanaka, O.
    Goshima, S.
    Kondou, H.
    Hoshi, H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 207 - 207
  • [38] Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial
    Shi, M.
    Li, Q.
    He, M.
    Guo, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S688 - S688
  • [39] Randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Torimura, Takuji
    Tanabe, Nobukazu
    Ikeda, Masafumi
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Nojiri, Shunsuke
    Hino, Keisuke
    Tsumura, Hidetaka
    Isoda, Norio
    Yasui, Kohichiroh
    Kuzuya, Teiji
    Okusaka, Takuji
    Furuse, Junji
    Kokudo, Norihiro
    Okita, Kiwamu
    Yoshimura, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I-II clinical trial
    Wu, KL
    Jiang, GL
    Qian, H
    Wang, LJ
    Yang, HJ
    Fu, XL
    Zhao, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05): : 1345 - 1350
12345